Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Healthtrust
Merck
Boehringer Ingelheim
Julphar
Teva
Colorcon
Citi
Fish and Richardson

Generated: February 22, 2018

DrugPatentWatch Database Preview

Metuchen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for METUCHEN PHARMS, and when can generic versions of METUCHEN PHARMS drugs launch?

METUCHEN PHARMS has one approved drug.

There are two US patents protecting METUCHEN PHARMS drugs on METUCHEN PHARMS drugs in the past three years.

There are fifty-three patent family members on METUCHEN PHARMS drugs in twenty-six countries and eight supplementary protection certificates in eight countries.

Summary for Metuchen Pharms
International Patents:53
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Metuchen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Metuchen Pharms STENDRA avanafil TABLET;ORAL 202276-002 Apr 27, 2012 RX Yes No 7,501,409 ➤ Try a Free Trial Y ➤ Try a Free Trial
Metuchen Pharms STENDRA avanafil TABLET;ORAL 202276-001 Apr 27, 2012 RX Yes No 6,656,935 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Metuchen Pharms STENDRA avanafil TABLET;ORAL 202276-003 Apr 27, 2012 RX Yes Yes 7,501,409 ➤ Try a Free Trial Y ➤ Try a Free Trial
Metuchen Pharms STENDRA avanafil TABLET;ORAL 202276-001 Apr 27, 2012 RX Yes No 7,501,409 ➤ Try a Free Trial Y ➤ Try a Free Trial
Metuchen Pharms STENDRA avanafil TABLET;ORAL 202276-003 Apr 27, 2012 RX Yes Yes 6,656,935 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Metuchen Pharms STENDRA avanafil TABLET;ORAL 202276-002 Apr 27, 2012 RX Yes No 6,656,935 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for METUCHEN PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 50 mg, 100 mg and 200 mg ➤ Subscribe 4/27/2016

Non-Orange Book US Patents for Metuchen Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,797,709 Aromatic nitrogen-containing 6-membered cyclic compounds ➤ Try a Free Trial
7,220,736 Pyrimidine compounds ➤ Try a Free Trial
7,273,868 Pyrazine derivatives ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Metuchen Pharms Drugs

Supplementary Protection Certificates for Metuchen Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0050 France ➤ Try a Free Trial PRODUCT NAME: AVANAFIL; REGISTRATION NO/DATE: EU/1/13/841 20130621
249 Luxembourg ➤ Try a Free Trial PRODUCT NAME: AVANAFIL
6 Finland ➤ Try a Free Trial
13/041 Ireland ➤ Try a Free Trial PRODUCT NAME: AVANAFIL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/841 20130613
2013000096 Germany ➤ Try a Free Trial PRODUCT NAME: AVANAFIL UND SEINE PHARMAZEUTISCH ANNEHMBAREN SALZE; REGISTRATION NO/DATE: EU/1/13/841 20130621
2013 00040 Denmark ➤ Try a Free Trial
90047-7 Sweden ➤ Try a Free Trial PRODUCT NAME: AVANAFIL; REG. NO/DATE: EU/1/13/841 20130621
00618 Netherlands ➤ Try a Free Trial PRODUCT NAME: AVANAFIL; REGISTRATION NO/DATE: EU/1/13/841 20130621
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Baxter
Harvard Business School
McKesson
Daiichi Sankyo
Express Scripts
Queensland Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot